As HCPs continue to be stretched for time to diagnose and interact with patients, health bots could help reduce HCP workload and drive patient engagement.
US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.
Digital innovation in Japan, health-tech trends, and social media top the list.
Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition
From gift bans to Google Assistant, POC to OPDP, MM&M staff members give their predictions on what to expect in healthcare marketing in 2018
Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business
It turns out the real goal is going after Washington's favorite whipping boy — high drug prices.
The digital health startup was founded in 2015.
FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance
DeVine will oversee the agency's health IT and medical device work.
Lighthouse received $50,000 for application aimed at providing more accessible and engaging care for those living with diabetes.
Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.
Innovation-minded executives share their thoughts and predictions for the year ahead.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.
CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate
FDA approves first Apple Watch health accessory; medical charity shared data with pharma donors; FDA approves opioid-addiction treatment
FDA releases information on Exondys 51; Sanofi's dengue vaccine faces new restrictions; Kellyanne Conway named opioid czar
How worried should the industry's other major players be?
Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.
The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.
Our understanding of how cancer develops and thrives has grown.
Technology like this could expand further to form better collaborations between pharma, payers and organized providers.
Marketers survey the pluses and minuses of the platform's new 280-character limit.
Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III
Do you recall what President Trump tweeted right after Merck's Kenneth Frazier resigned from his American Manufacturing Council?
The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.
Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
The e-giant is reportedly doing everything from starting secret labs and online pharmacies to redefining the hospital experience and democratizing health data.
Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
Facebook itself has more than six million health-related groups.
Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.
The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.
Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.
Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.
Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity
Teva names new CEO; Allergan transfers Restasis patent to skirt competition; Google invests in oncology
The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.
Calman is joining the technology company as VP of comms for Watson Health.
Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.
Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.
Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.
Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement
FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi
Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.
Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.
Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.
The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
Consent forms and reimbursement are the main deterrents of offering the service.
With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes
Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug
Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.
The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
Robert Califf stepped down from his role as FDA commissioner in January.
FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations
To demonstrate the power of goggles equipped with AR and VR, the assistive technology company recreated the event on Facebook Live this weekend.
The artificial pancreas can provide value to the health system.
One executive referred to AI as a "black box" and as the "Tower of Babel."
In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.
The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.
HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.
Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients
Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.
The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.
The drugmaker saw a gap in patient-physician conversation about retinal disease.
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.
Susannah Fox is the former chief technology officer for HHS.
Dr. Mylene Yao is co-founder and CEO of Univfy.
Sam Frons is founder of Addicaid.
Stephanie Tilenius is CEO and co-founder of Vida Health.
Jenny Barnett is chief scientific officer at Cambridge Cognition.
Deborah Estrin is co-founder of Open mHealth.
Adrian Aoun is the CEO and founder of Forward.
John Lieberman is the founder of NYC Medtech.
Rick Altinger is CEO of Glooko.
Tom Kottler is co-founder and CEO of HealthPrize Technologies.
Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.
Libbe Englander is founder and CEO of Pharm3r.
Brandi Davis-Dusenbery is CEO of Seven Bridges.
Dr. Amy Baxter is founder and CEO of MMJ Labs.
Dr. Robert Robbins is president and CEO of the Texas Medical Center.
Lynn O'Connor Vos is CEO of ghg.
Olivier Noel is founder and CEO of DNAsimple.
Thomas Goetz is the CEO and co-founder of Iodine.
Amy Molyneux is co-founder and EVP of Meta.
Melinda Richter is head of JLABS at Johnson & Johnson.
MM&M honors 40 upstarts and veteran innovation gurus.